HMR Supports Individuals Using GLP-1s to Enhance Weight Loss and Health Outcomes

SIOUX FALLS, SD / ACCESSWIRE / August 3, 2023 / HMR, a leading provider of medically-supervised weight management and lifestyle intervention programs, is pleased to announce its dedicated support for individuals using weight-loss medications, particularly the type commonly known as GLP-1s. Since 1983, HMR has helped people achieve significant weight loss while instilling lasting lifestyle changes for improved health and overall quality of life.

HMR logo
HMR logo

The HMR program is available at premier hospitals and medical centers nationwide, offering two comprehensive treatment options: in-person medically-supervised program and Healthy Solutions® at Home, which utilizes supportive technology and health coaching. Both options provide effective assistance to individuals using weight-loss medications by combining health coaching, dietary modifications, and strategies for increased physical activity.

Christine Weithman, MBA, RD, LDN, FAND, Lead Dietitian at HMR, emphasizes the importance of incorporating lifestyle modifications alongside medication use. She says, “Although GLP-1s exhibit remarkable effectiveness, their true potential shines when combined with a comprehensive lifestyle and nutrition program. Sole medication isn’t sufficient for achieving lasting results. The significance of embracing lifestyle modification through food choices and physical activity cannot be emphasized enough. At HMR, we support sustainable improvements.”

HMR is proud to present its published results, demonstrating the effectiveness of its programs:

  • In-person Program: Participants completing the in-clinic Decision-Free® plan achieve an average weight loss of 43-66 lbs. over 12-26 weeks.1
  • At-home Program: Participants completing the Healthy Solutions® at Home program with virtual coaching achieve an average weight loss of 23 lbs. at 12 weeks and 28 lbs. at 26 weeks.2

HMR’s focus on healthy behavior change is crucial for long-term weight management. Christi Cummings, Director of Nursing at HMR, emphasizes that “Along with HMR’s behavior change approach, health care providers can be assured that those using or considering GLP-1s can improve weight-loss outcomes, achieve long-term weight management, and enhance overall health.”

Ryan Niparts, CEO of HMR, shares the organization’s commitment to revolutionizing weight management through a holistic approach. “By integrating cutting-edge medications like GLP-1s with personalized nutrition and lifestyle plans, we are confident that our method will bring about a transformative impact in the lives of countless individuals,” he says.

HMR ensures that individuals utilizing GLP-1s will follow a structured HMR plan while receiving supportive strategies to adjust their diet for food volume, meal timing, and product variety. The methods employed by HMR are supported by GLP-1 providers who work closely with the HMR program.

To learn more about how HMR’s medically-supervised programs can support your weight-loss journey while using GLP-1s, visit www.hmrprogram.com. Healthcare Providers, visit www.hmrprogram.com/for-professionals.

1 J Am Diet Assoc 2009;109:1417-1421; Postgrad Med 2011;123:205-213; Int J Obes 2007;31:1270-1276; Obes 2013;21:1951-1959.

2 J A Diet Assoc 2009; 109:1417-1421; Int J Obes 2007; 31:488-493; J Am Coll Nutr 2005; 24:347-353.

These studies were supported and/or sponsored by HMR, including financial support in some cases. Some of the investigators in some of the studies were employees of HMR and/or members of the HMR Medical Advisory Board.

Contact Information

Ryan Niparts
CEO, HMR Plan
ryan.niparts@profileplan.com
716-510-3316

SOURCE: HMR Plan

View source version on accesswire.com:
https://www.accesswire.com/771821/HMR-Supports-Individuals-Using-GLP-1s-to-Enhance-Weight-Loss-and-Health-Outcomes

Staff

Recent Posts

Cenegenics Improves Operational Efficiency with Domo

SILICON SLOPES, Utah--(BUSINESS WIRE)--Domo (Nasdaq: DOMO) announced today that Cenegenics, a leader in the performance…

10 hours ago

Lophos Holdings Inc. Announces the Completion of Securities Purchase Agreement with ThreeD Capital Inc.

Vancouver, British Columbia--(Newsfile Corp. - June 20, 2024) - Lophos Holdings Inc. (CSE: MESC) ("Lophos"…

10 hours ago

Pearl Health CEO Michael Kopko recognized as an EY Entrepreneur Of The Year® 2024 New York Award Winner

NEW YORK, June 20, 2024 /PRNewswire/ -- Ernst & Young LLP (EY US) today announced…

10 hours ago

ProviderTrust Named Top Place to Work by Modern Healthcare and The Tennessean Top Workplaces

NASHVILLE, Tenn., June 20, 2024 /PRNewswire/ -- ProviderTrust was recently selected by Modern Healthcare as one…

10 hours ago

Registration Opens for DeviceTalks West 2024

Why Did You Get into MedTech? Join us at DeviceTalks West to Learn from other…

13 hours ago

Gemina Laboratories Commences Trading on the OTCQB Market in the United States

Gemina Laboratories (OTCQB: GLABF), (CSE: GLAB), (FRA: 817) expands investor reach to U.S. by posting…

13 hours ago